Skip to content

HQY

HealthEquity, Inc.

Stock

$90.04+0.67 (+0.75%)Close Oct 2, 2026

Income statement

LineLast 12 monthsFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Revenue$1.4B$1.3B$1.2B$1,000M$862M$757M$734M$532M$287M$230M$178M$127M$88M$62M$46M
Cost of revenue$392M$400M$423M$377M$370M$332M$318M$206M$106M$95M$72M$54M$40M$29M$22M
Gross profit$970M$913M$777M$623M$492M$425M$415M$326M$181M$135M$106M$73M$48M$33M$24M
R&D$278M$263M$240M$219M$193M$157M$125M$78M$35M$27M$22M$17M$11M$7.1M$4.2M
SG&A$230M$215M$223M$183M$166M$144M$134M$105M$63M$48M$38M$27M$19M$12M$11M
Other operating expenses$111M$113M$152M$103M$123M$148M$122M$67M$5.9M$4.9M$4.3M$2.2M$1.6M$1.6M$1.6M
Operating income$351M$322M$162M$118M$9.1M−$24M$34M$77M$78M$54M$41M$26M$17M$12M$7.1M
Non-operating income−$43M−$45M−$46M−$43M−$47M−$43M−$30M−$34M−$1.9M−$2.2M−$1.1M−$589K−$1.1M−$6.2M−$590K
Pretax income$309M$277M$116M$75M−$38M−$67M$4.1M$43M$76M$52M$40M$26M$16M$5.4M$6.5M
Taxes$72M$62M$19M$19M−$12M−$22M−$4.7M$3.5M$1.9M$4.8M$14M$8.9M$5.6M$4.1M−$4.7M
Net income$236M$215M$97M$56M−$26M−$44M$8.8M$40M$74M$47M$26M$17M$10M$1.2M$11M
Diluted EPS$2.76$2.46$1.09$0.64−$0.31−$0.53$0.12$0.58$1.17$0.77$0.44$0.28$0.21−$1.26$0.25
Diluted shares—87.5M88.8M87.0M84.4M83.1M75.7M68.5M63.4M61.9M59.9M58.9M51.9M5.7M37.5M
Revenue growth—+9.5%+20.0%+16.0%+13.9%+3.1%+37.9%+85.2%+25.1%+28.7%+40.7%+44.3%+41.7%+34.6%—
Gross margin71.2%69.5%64.8%62.3%57.1%56.1%56.6%61.3%63.1%58.8%59.6%57.3%54.6%52.9%52.3%
Operating margin25.8%24.6%13.5%11.8%1.1%−3.2%4.6%14.5%27.0%23.7%23.1%20.6%19.2%18.6%15.4%
Net margin17.4%16.4%8.1%5.6%−3.0%−5.9%1.2%7.5%25.7%20.6%14.8%13.1%11.6%2.0%24.2%

Revenue to net income